Alotaibi F, Alshammari K, Alotaibi B, Alsaab H
Front Pharmacol. 2024; 14:1280591.
PMID: 38264532
PMC: 10803447.
DOI: 10.3389/fphar.2023.1280591.
Dada S, Ellis S, Wood C, Nohara L, Dreier C, Garcia N
Front Immunol. 2023; 13:982082.
PMID: 36923728
PMC: 10010394.
DOI: 10.3389/fimmu.2022.982082.
Zhu X, Cai H, Zhao L, Ning L, Lang J
Oncotarget. 2017; 8(38):64607-64621.
PMID: 28969098
PMC: 5610030.
DOI: 10.18632/oncotarget.19929.
Del Campo A, Carretero J, Munoz J, Zinchenko S, Ruiz-Cabello F, Gonzalez-Aseguinolaza G
Cancer Gene Ther. 2014; 21(8):317-32.
PMID: 24971583
DOI: 10.1038/cgt.2014.32.
Brahmer J
Semin Oncol. 2014; 41(1):126-32.
PMID: 24565586
PMC: 4732704.
DOI: 10.1053/j.seminoncol.2013.12.014.
The current state of head and neck cancer gene therapy.
Thomas S, Grandis J
Hum Gene Ther. 2009; 20(12):1565-75.
PMID: 19747066
PMC: 2829451.
DOI: 10.1089/hum.2009.163.
Gene therapy for carcinoma of the breast.
Stoff-Khalili M, Dall P, Curiel D
Cancer Gene Ther. 2006; 13(7):633-47.
PMID: 16410823
PMC: 1781527.
DOI: 10.1038/sj.cgt.7700929.
Gene transfer preferentially selects MHC class I positive tumour cells and enhances tumour immunogenicity.
Hacker U, Schildhauer I, Barroso M, Kofler D, Gerner F, Mysliwietz J
Cancer Immunol Immunother. 2005; 55(5):547-57.
PMID: 16044254
PMC: 11030393.
DOI: 10.1007/s00262-005-0035-4.
Increased expression of CEA and MHC class I in colorectal cancer cell lines exposed to chemotherapy drugs.
Ohtsukasa S, Okabe S, Yamashita H, Iwai T, Sugihara K
J Cancer Res Clin Oncol. 2003; 129(12):719-26.
PMID: 14564514
DOI: 10.1007/s00432-003-0492-0.
The history, evolution, and clinical use of dendritic cell-based immunization strategies in the therapy of brain tumors.
Fecci P, Mitchell D, Archer G, Morse M, Lyerly H, Bigner D
J Neurooncol. 2003; 64(1-2):161-76.
PMID: 12952297
DOI: 10.1007/BF02700031.
HLA-DR and beta 2 microglobulin expression in medullary and atypical medullary carcinoma of the breast: histopathologically similar but biologically distinct entities.
Feinmesser M, Sulkes A, Morgenstern S, Sulkes J, Stern S, Okon E
J Clin Pathol. 2000; 53(4):286-91.
PMID: 10823125
PMC: 1731169.
DOI: 10.1136/jcp.53.4.286.
Reduced phosphorylation of p50 is responsible for diminished NF-kappaB binding to the major histocompatibility complex class I enhancer in adenovirus type 12-transformed cells.
Kushner D, Ricciardi R
Mol Cell Biol. 1999; 19(3):2169-79.
PMID: 10022903
PMC: 84009.
DOI: 10.1128/MCB.19.3.2169.
Direct intratumoral gene transfer of the herpes simplex virus thymidine kinase gene with DNA-liposome complexes: growth inhibition of tumors and lack of localization in normal tissues.
Takakuwa K, Fujita K, Kikuchi A, Sugaya S, Yahata T, Aida H
Jpn J Cancer Res. 1997; 88(2):166-75.
PMID: 9119745
PMC: 5921354.
DOI: 10.1111/j.1349-7006.1997.tb00362.x.
LMP-associated proteolytic activities and TAP-dependent peptide transport for class 1 MHC molecules are suppressed in cell lines transformed by the highly oncogenic adenovirus 12.
Groettrup M, Soza A, Kloetzel P, Ehrlich R
J Exp Med. 1996; 183(2):499-514.
PMID: 8627162
PMC: 2192445.
DOI: 10.1084/jem.183.2.499.
Loss of antigen-presenting molecules (MHC class I and TAP-1) in lung cancer.
Korkolopoulou P, Kaklamanis L, Pezzella F, Harris A, Gatter K
Br J Cancer. 1996; 73(2):148-53.
PMID: 8546899
PMC: 2074307.
DOI: 10.1038/bjc.1996.28.
Locus-specific de novo methylation down-regulates MHC class I in S49 lymphomas.
Rubocki R, Berrigan B, Speaks S, Wisecarver J
Immunogenetics. 1996; 43(1-2):63-7.
PMID: 8537124
DOI: 10.1007/BF00186605.
Evidence for the involvement of a nuclear NF-kappa B inhibitor in global down-regulation of the major histocompatibility complex class I enhancer in adenovirus type 12-transformed cells.
Liu X, Ge R, Ricciardi R
Mol Cell Biol. 1996; 16(1):398-404.
PMID: 8524321
PMC: 231015.
DOI: 10.1128/MCB.16.1.398.
Increased projection of MHC and tumor antigens in murine B16-BL6 melanoma induced by hydrostatic pressure and chemical crosslinking.
Ramakrishna V, Eisenthal A, Skornick Y, Shinitzky M
Cancer Immunol Immunother. 1993; 36(5):293-9.
PMID: 8477415
PMC: 11038729.
DOI: 10.1007/BF01741167.
Retroviral transduction of interferon-gamma cDNA into a nonimmunogenic murine fibrosarcoma: generation of T cells in draining lymph nodes capable of treating established parental metastatic tumor.
Shiloni E, Karp S, Custer M, Shilyansky J, Restifo N, Rosenberg S
Cancer Immunol Immunother. 1993; 37(5):286-92.
PMID: 8402732
PMC: 2248452.
DOI: 10.1007/BF01518450.
Comparison of the potential therapeutic effects of interleukin 2 or interleukin 4 secretion by a single tumour.
Patel P, Flemming C, Russell S, McKay I, MacLennan K, Box G
Br J Cancer. 1993; 68(2):295-302.
PMID: 8347485
PMC: 1968575.
DOI: 10.1038/bjc.1993.331.